| New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022 | 1520 | 2022 |
| Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ... Nature communications 12 (1), 3417, 2021 | 244 | 2021 |
| Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: the GR@ ACE project S Moreno‐Grau, I De Rojas, I Hernández, I Quintela, L Montrreal, ... Alzheimer's & Dementia 15 (10), 1333-1347, 2019 | 158 | 2019 |
| Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo … AM Lacosta, M Pascual-Lucas, P Pesini, D Casabona, V Pérez-Grijalba, ... Alzheimer's research & therapy 10, 1-13, 2018 | 102 | 2018 |
| Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia C Abdelnour, I van Steenoven, E Londos, F Blanc, B Auestad, ... Movement Disorders 31 (8), 1203-1208, 2016 | 102 | 2016 |
| Long-term cognitive decline in dementia with Lewy bodies in a large multicenter, international cohort MG Kramberger, B Auestad, S Garcia-Ptacek, C Abdelnour, JG Olmo, ... Journal of Alzheimer's Disease 57 (3), 787-795, 2017 | 100 | 2017 |
| β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies D Ferreira, SA Przybelski, TG Lesnick, AW Lemstra, E Londos, F Blanc, ... Neurology 95 (24), e3257-e3268, 2020 | 99 | 2020 |
| GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study A Rongve, A Witoelar, A Ruiz, L Athanasiu, C Abdelnour, J Clarimon, ... Scientific reports 9 (1), 7013, 2019 | 81 | 2019 |
| Challenges for service robots—requirements of elderly adults with cognitive impairments A Korchut, S Szklener, C Abdelnour, N Tantinya, J Hernández-Farigola, ... Frontiers in neurology 8, 228, 2017 | 77 | 2017 |
| New insights on the genetic etiology of Alzheimer’s and related dementia C Bellenguez, F Küçükali, I Jansen, V Andrade, S Moreno-Grau, N Amin, ... MedRxiv, 2020.10. 01.20200659, 2020 | 74 | 2020 |
| Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease D Sánchez, M Castilla-Marti, O Rodríguez-Gómez, S Valero, A Piferrer, ... Scientific reports 8 (1), 16345, 2018 | 68 | 2018 |
| Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis N Roberto, MJ Portella, M Marquié, M Alegret, I Hernández, A Mauleón, ... Scientific reports 11 (1), 6448, 2021 | 65 | 2021 |
| Influence of sampling and recruitment methods in studies of subjective cognitive decline O Rodríguez-Gómez, C Abdelnour, F Jessen, S Valero, M Boada Journal of Alzheimer's Disease 48 (s1), S99-S107, 2015 | 64 | 2015 |
| Dementia care in times of COVID-19: Experience at Fundació ACE in Barcelona, Spain A Benaque, MJ Gurruchaga, C Abdelnour, I Hernández, P Cañabate, ... Journal of Alzheimer’s Disease 76 (1), 33-40, 2020 | 60 | 2020 |
| The role of verb fluency in the detection of early cognitive impairment in Alzheimer’s disease M Alegret, M Peretó, A Pérez, S Valero, A Espinosa, G Ortega, ... Journal of Alzheimer's Disease 62 (2), 611-619, 2018 | 60 | 2018 |
| Association of plasma p-tau181 and p-tau231 concentrations with cognitive decline in patients with probable dementia with Lewy bodies MC Gonzalez, NJ Ashton, BF Gomes, DA Tovar-Rios, F Blanc, TK Karikari, ... JAMA neurology 79 (1), 32-37, 2022 | 59 | 2022 |
| Perspectives and challenges in patient stratification in Alzheimer’s disease C Abdelnour, F Agosta, M Bozzali, B Fougère, A Iwata, R Nilforooshan, ... Alzheimer's research & therapy 14 (1), 112, 2022 | 58 | 2022 |
| Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design JB Toledo, C Abdelnour, RS Weil, D Ferreira, F Rodriguez‐Porcel, ... Alzheimer's & Dementia 19 (1), 318-332, 2023 | 57 | 2023 |
| Visual impairment in aging and cognitive decline: experience in a Memory Clinic M Marquié, M Castilla-Martí, S Valero, J Martínez, D Sánchez, ... Scientific reports 9 (1), 8698, 2019 | 57 | 2019 |
| Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI) I de Rojas, J Romero, O Rodriguez-Gomez, P Pesini, A Sanabria, ... Alzheimer's Research & Therapy 10, 1-12, 2018 | 51 | 2018 |
Mercè Boada, MD, PhDNeuróloga. MD, PhDDirección de correo verificada de fundacioace.com